Expression of the high molecular weight fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of protein kinases C δ and ε and ERK activation

被引:25
|
作者
Gaubert, F
Escaffit, F
Bertrand, C
Korc, M
Pradayrol, L
Clemente, F
Estival, A
机构
[1] CHU Rangueil, INSERM U531, ILB, F-31054 Toulouse, France
[2] Univ Calif Irvine, Div Endocrinol Diabet & Metab, Irvine, CA 92697 USA
关键词
D O I
10.1074/jbc.M001184200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The high molecular weight (HMW) fibroblast growth factor (FGF)-2 isoform of 210 amino acids initiated at a CUG start codon possesses a nuclear localization sequence and is not secreted, In contrast, the low molecular weight (LMW) isoform of 155 amino acids initiated at the AUG start codon can be secreted and activates the cell surface FGF receptors, The two isoforms possess different biological properties; however, little is known about the intracrine regulatory mechanisms involved in the biological effects of the HMW FGF-2 isoform, Using pancreatic cells stably transfected with cDNAs leading to the expression of either the HMW FGF-2 (A3 cells) or the LMW form (A5 cells), we provide evidence that the two FGF-2 isoforms differentially modulate PKC levels. The LMW FGF-2 up-regulated the PKC epsilon levels by 1.6-fold; by contrast the HMW isoform down-regulated the level of this PKC isotype by about 3-fold and increased the amount of PKC delta by 1.7-fold. PKC mRNAs were also modified, suggesting that PKC expression was regulated at a pretranslational level. Additionally, expression of different levels of the HMW FGF-2 with an inducible expression system confirmed the role of this isoform on PKC delta and epsilon expressions. Increased activation of ERK-1 and -2 was also observed in cells expressing the HMW FGF-2, By using different PKC inhibitors and a dominant negative PKC delta, it was found that ERK activation was PKC delta -dependent. These data indicate that expression of HMW FGF-2 can modify PKC levels by acting at the intracellular level and that the overexpression of PKC delta induces ERK-1/2 activation. The expression of a dominant negative FGFR1 did not reduce ERK-1/2 activation by the HMW FGF-2, suggesting that ERK activation does not require FGFR activity. The signaling cascade downstream of ERK might be involved in the known mitogenic effect exerted by this FGF-2 isoform.
引用
收藏
页码:1545 / 1554
页数:10
相关论文
共 32 条
  • [1] Gene Targeted Ablation of High Molecular Weight Fibroblast Growth Factor-2
    Azhar, Mohamad
    Yin, Moying
    Zhou, Ming
    Li, Hongqi
    Mustafa, Marwan
    Nusayr, Eyad
    Keenan, Jack B.
    Chen, Hwudaurw
    Pawlosky, Sharon
    Gard, Connie
    Grisham, Christina
    Sanford, L. Philip
    Doetschman, Tom
    DEVELOPMENTAL DYNAMICS, 2009, 238 (02) : 351 - 357
  • [2] Cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: The role of JNK signaling
    Liao, SY
    Porter, D
    Newman, G
    Doetschman, T
    Schultz, JEJ
    CIRCULATION, 2005, 112 (17) : U308 - U309
  • [3] The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: The role of JNK signaling
    Liao, Siyun
    Porter, Darius
    Scott, Alana
    Newman, Gilbert
    Doetschman, Thomas
    Schultz, Jo El J.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 (01) : 106 - 120
  • [4] Biochemical analysis of the arginine methylation of high molecular weight fibroblast growth factor-2
    Klein, S
    Carroll, JA
    Chen, Y
    Henry, MF
    Henry, PA
    Ortonowski, IE
    Pintucci, G
    Beavis, RC
    Burgess, WH
    Rifkin, DB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (05) : 3150 - 3157
  • [5] Biological Functions of the Low and High Molecular Weight Protein Isoforms of Fibroblast Growth Factor-2 in Cardiovascular Development and Disease
    Liao, Siyun
    Bodmer, Janet
    Pietras, Daniel
    Azhar, Mohamad
    Doetschman, Tom
    Schultz, Jo El J.
    DEVELOPMENTAL DYNAMICS, 2009, 238 (02) : 249 - 264
  • [6] Evidence for the low molecular weight isoform of fibroblast growth factor-2 to protect against ischemia-reperfusion injury
    Liao, S
    Newman, G
    Doetschman, T
    Schultz, JEJ
    CIRCULATION, 2003, 108 (17) : 187 - 187
  • [7] High Molecular Weight Fibroblast Growth Factor-2 in the Human Heart Is a Potential Target for Prevention of Cardiac Remodeling
    Santiago, Jon-Jon
    McNaughton, Leslie J.
    Koleini, Navid
    Ma, Xin
    Bestvater, Brian
    Nickel, Barbara E.
    Fandrich, Robert R.
    Wigle, Jeffrey T.
    Freed, Darren H.
    Arora, Rakesh C.
    Kardami, Elissavet
    PLOS ONE, 2014, 9 (05):
  • [8] The High Molecular Weight Isoforms of Fibroblast Growth Factor-2 are Necessary for Postischemic Hindlimb Functional Recovery and Revascularization
    Adeyemo, Adeola
    Stephens, Blake
    Zhang, Yu
    Dale, Jacob R.
    Hoying, James B.
    El Schultz, Jo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40
  • [9] Methylation of high molecular weight fibroblast growth factor-2 determines post-translational increases in molecular weight and affects its intracellular distribution
    Pintucci, G
    Quarto, N
    Rifkin, DB
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 (08) : 1249 - 1258
  • [10] Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction
    Manning, Janet R.
    Perkins, Sarah O.
    Sinclair, Elizabeth A.
    Gao, Xiaoqian
    Zhang, Yu
    Newman, Gilbert
    Pyle, W. Glen
    Schultz, Jo El J.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2013, 304 (10): : H1382 - H1396